L.M. Jost - Concepedia

Author

L.M. Jost

University Hospital of Zurich

Also Known As

L Jost, L M Jost, L. Jost, L. M. Jost, L.M. Jost, LM Jost

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Zurich Kantonsspital Baselland Standort Bruderholz University Hospital of Bern Triemli Hospital European Society for Medical Oncology

About

L.M. Jost is an author at University Hospital of Zurich specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	1.2K
2	Health Sciences	4	4	257
3	Blood Transplantation	1	1	46
4	Cell Biology	1	1	185
5	Cellular Therapies	1	1	48

L.M. Jost

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Paolo G. Casali, L.M. Jost, Peter Reichardt, Annals of Oncology Surgical OncologyGastrointestinal OncologyMedicineGastroenterologyGastrointestinal Stromal Tumors	2008	187
Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells L.M. Jost, John M. Kirkwood, Theresa L. Whiteside Journal of Immunological Methods Tumor BiologyMedicinePhotocarcinogenesisMelanomaOther Tumor Cells	1992	185
Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper Paolo G. Casali, Paolo Bruzzi, Jan Bogaerts, Annals of Oncology	2014	114
Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Reinhard Dummer, Axel Hauschild, Merlin Guggenheim, Annals of Oncology Dermoscopic ImageSurgical OncologySkin CancerMedicineMelanoma	2010	105
Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies. Rolf A. Stahel, L.M. Jost, Thomas Cerny, Journal of Clinical Oncology	1994	100
Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study Monika Jermann, L.M. Jost, Ch. Taverna, Annals of Oncology Hematological MalignancyLymphoid NeoplasiaEffective Salvage TherapyMedicineImmunology	2004	100
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia Jakob Passweg, Marco Rabusin, Maurizio Musso, British Journal of Haematology	2004	87
ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer Bernhard C. Pestalozzi, Elisabeth Luporsi-Gely, L.M. Jost, Annals of Oncology Surgical OncologyOncologyBreast OncologyCancer ManagementPrimary Breast Cancer	2005	84
Thyroiditis after treatment with interleukin-2 and interferon α-2a Gabriella Pichert, L.M. Jost, L Zöbeli, British Journal of Cancer InflammationCytokineInterferon α-2AAutoimmune DiseaseImmunodeficiencies	1990	71
Acute CNS infection by <i>Trypanosoma cruzi</i> (Chagas' disease) in immunosuppressed patients R. Leiguarda, Alfredo J. Roncoroni, A.L. Taratuto, Neurology	1990	71

Page 1